COMMONWEALTH OF AUSTRALIA
Instrument number PB 46 of 2012
Amendment determination under paragraph 98C(1)(b) of the National Health Act 19531
 
I, Felicity McNeill, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.
 
Dated                                          19 July 2012
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
Amendment determination — conditions
1              Commencement                                                        
                This instrument commences on 1 August 2012.
2              Amendment of the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1            Amendments
 
[1]        Schedule 1, after entry for Cefaclor with Water ─ Purified BP in the form Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL
insert in the columns in the order indicated:
Cefuroxime with Water ─ Purified BP
Powder for oral suspension 125 mg (as axetil) per 5 mL, 70 mL
 
[2]        Schedule 4, after entry for Cefaclor in the form Powder for oral suspension
250 mg (as monohydrate) per 5 mL, 75 mL
insert in the columns in the order indicated:
Cefuroxime
Powder for oral suspension 125 mg (as axetil) per 5 mL, 70 mL
 
[3]        Schedule 4, entry for Oestradiol
omit:
 
Transdermal patches 2 mg, 8
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 
See http://www.frli.gov.au.